In Vivo CRO Market To Witness A Significant Growth Of USD 7.92 Billion By 2030
San Francisco, 7 Sep 2022: The Report In Vivo CRO Market Size, Share & Trends Analysis Report By Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Pain Management, Oncology), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030 The global in vivo cro market size is expected to reach USD 7.92 billion by 2030, registering a CAGR of 8.2% according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand. In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to the rapid growth of generics, patent expirations, and introduction of biosimilar equivalents